Showing results (1761-1770 of 1,799) with videos related to
Sort By:
Pageof 180
Neurology|April 28, 2004
Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyJ A French, A M Kanner, J Bautista, et al.The New England Journal of Medicine|June 6, 2019
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic MelanomaCaroline Robert, Jean J Grob, Daniil Stroyakovskiy, et al.The Journal of Infectious Diseases|February 25, 2012
Multicohort genomewide association study reveals a new signal of protection against HIV-1 acquisitionSophie Limou, Olivier Delaneau, Daniëlle van Manen, et al.Epilepsia|April 23, 2004
Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy SocietyJacqueline A French, Andres M Kanner, Jocelyn Bautista, et al.The Review of Scientific Instruments|March 5, 2008
A status report of the multipurpose superconducting electron cyclotron resonance ion sourceG Ciavola, S Gammino, S Barbarino, et al.Oncoimmunology|July 4, 2012
TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patientsPia Kvistborg, Chengyi Jenny Shu, Bianca Heemskerk, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2018
Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)Richard D Carvajal, Sophie Piperno-Neumann, Ellen Kapiteijn, et al.NEJM Evidence|May 22, 2024
CAR T-Cell Immunotherapy in Minority Patients with LymphomaGuido Ghilardi, Staci Williamson, Raymone Pajarillo, et al.The Journal of Pharmacology and Experimental Therapeutics|June 5, 2020
MK-8719, a Novel and Selective <i>O</i>-GlcNAcase Inhibitor That Reduces the Formation of Pathological Tau and Ameliorates Neurodegeneration in a Mouse Model of TauopathyXiaohai Wang, Wenping Li, Jacob Marcus, et al.Clinical Genetics|August 2, 2019
Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease patientsYasser Salama, Saleh Albanyan, Marta Szybowska, et al.Pageof 180